BCR::ABL1 Kinase N-lobe Mutants Confer Moderate to High Degrees of Resistance to Asciminib.
Leyte-Vidal A, Garrido Ruiz D, DeFilippis R, Leske IB, Rea D, Phan S, Miller KB, Hu F, Mase A, Shan Y, Hantschel O, Jacobson MP, Shah NP.
Leyte-Vidal A, et al. Among authors: shan y.
Blood. 2024 Apr 21:blood.2023022538. doi: 10.1182/blood.2023022538. Online ahead of print.
Blood. 2024.
PMID: 38643492